Psy166 - Market Access Trends for Advanced Therapy Medicinal Products (Atmps) in Europe

Value in Health- United Kingdom

doi 10.1016/j.jval.2018.09.2740

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Genome‐edited Adult Stem Cells: Next‐generation Advanced Therapy Medicinal Products (ATMPs)

Stem cells translational medicine
MedicineDevelopmental BiologyCell Biology
2020English

Php307 - Reimbursement of Advanced Therapy Medicinal Products in Europe

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Recent Progress in European Advanced Therapy Medicinal Products and Beyond

Frontiers in Bioengineering and Biotechnology
BioengineeringBiomedical EngineeringHistologyBiotechnology
2018English

Trends in Time to Market Access in Europe - Is It Getting Better?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Risk of Discontinuation of Advanced Therapy Medicinal Products Clinical Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Php369 - Challenges in Achieving Market Access Success for Advanced Therapies in Europe: A Case Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pnd110 - Gene Therapy Products – Market Access Situation in Eu and in Slovakia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report From the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014

Transfusion Medicine and Hemotherapy
AllergyImmunologyHematology
2015English

Market Access Proposals for Non-Agricultural Products

2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy